the circa-dose trial: key results from the primary and secondary analysis and clinical implications.
Published 4 years ago • 95 plays • Length 29:58Download video MP4
Download video MP3
Similar videos
-
4:42
esc 23: compare-cryo: polarx vs arctic front cryoballoons for pvi in pts with paroxysmal af
-
1:00
pulsed af trial
-
11:06
esc 22 late-breaker discussion: the advor trial
-
4:25
hfsa 24: expanded: atrial secondary mr outcomes following teer
-
12:24
hrs 2021: ganglia-af trial
-
6:36
hrs 22: outcomes from the mental-af trial | dr julia a lurz
-
7:09
hrs 2021: results from the stroke-vt trial
-
13:00
atrial fibrillation and catheter ablation | nejm
-
38:48
radcliffe & cardionerds @aha22: empa-kidney: empagliflozin & cv outcomes in patients with ckd
-
15:01
5.75 hz frequency for atrial fibrillation - isochronic binaural beats: 15 min rife healing treatment
-
15:17
acc 21: findings from the raft-af trial
-
2:31
esc 24: the sham-pvi study
-
7:44
2-year outcomes of the biostemi rct and its implications for clinical practice
-
7:19
acc.24: the liberate-cvd trial
-
13:07
radcliffe & cardionerds @aha22: the progressive-af trial
-
6:41
acc.24: the tact2 trial
-
29:53
the radcliffe cardiology podcast | vhpsd versus conventional catheter ablation in af
-
19:34
how to: zero and near-zero fluoroscopic ablation of cardiac arrhythmias
-
5:34
hrs 22: results from the multicenter us cardioneural ablation registry | dr roderick tung
-
4:50
esc 23: surhyb trial: hybrid ablation in persistent atrial fibrillation
-
4:18
acc 24: periprocedural cerebral embolisms and catheter ablation of af: the embo-abl study